Newfeed

– Results presented from over a decade of treatment with velmanase alfa in alpha-mannosidosis – – Company also presents immunogenicity and tolerability data from pegunigalsidase alfa clinical trial program in Fabry disease – – Additional presentations provide new insights on pr

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: